Utilizing VY fasciocutaneous advancement flaps for vulvar reconstruction

Abstract Objectives We aimed to analyze the outcomes of patients who underwent vulvectomywith subsequent V Y fasciocutaneous flap reconstruction. Methods All medical records of all patients who underwent vulvectomieswith V Y fasciocutaneous flap reconstruction from January 2007 to June 2016 were retrospectively reviewed. Patient clinical and surgical data, demographics, and outcomes were abstracted. Results Of the 27 patients, 42 flaps were transferred. A simple vulvectomywas performed in 8 (30%) patients, partial radical vulvectomyin 15 (56%), and radical vulvectomyin 4 (15%). The median area of defect was 30 cm 2 . Minor wound separations occurred in 9 patients (33%). Infectious complications occurred in 4 patients (15%); this included urinary tract infections in 2 (50%), postoperative feversin 2 (50%), and sepsis in 1 (25%) patient with a UTI. There were no instances of flap necrosis, wound dehiscence, or wound infections. Black racewas more likely to be associated with an infectious complication with 3 (75%) patients, compared to white race with 1 (4%) patient ( p Y fasciocutaneous flap infectious complications or minor wound separations. Conclusions The use of a V Y fasciocutaneous advancement flap for vulvar reconstruction is safe and associated with mostly minor complications. Infectious complications were more frequently associated with diabetes, black race, and HIV.